Annual Operating Profit
-$436.05 M
+$131.88 M+23.22%
31 December 2023
Summary:
Biohaven Pharmaceutical Holding annual operaing income is currently -$436.05 million, with the most recent change of +$131.88 million (+23.22%) on 31 December 2023. During the last 3 years, it has fallen by -$321.55 million (-280.81%). BHVN annual operating profit is now -4397.23% below its all-time high of -$9.70 million, reached on 31 December 2015.BHVN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$178.17 M
+$155.60 M+46.62%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding quarterly operating income is currently -$178.17 million, with the most recent change of +$155.60 million (+46.62%) on 30 September 2024. Over the past year, it has dropped by -$67.62 million (-61.17%). BHVN quarterly operating profit is now -5872.78% below its all-time high of -$2.98 million, reached on 01 March 2016.BHVN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$848.89 M
-$67.62 M-8.66%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding TTM operating income is currently -$848.89 million, with the most recent change of -$67.62 million (-8.66%) on 30 September 2024. Over the past year, it has dropped by -$353.14 million (-71.23%). BHVN TTM operating profit is now -28357.63% below its all-time high of -$2.98 million, reached on 01 March 2016.BHVN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BHVN Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.2% | -61.2% | -71.2% |
| 3 y3 years | -280.8% | -250.2% | -698.0% |
| 5 y5 years | -94.2% | -32.0% | -77.2% |
BHVN Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -280.8% | +23.2% | -250.2% | +46.6% | -698.0% | at low |
| 5 y | 5 years | -280.8% | +23.2% | -250.2% | +46.6% | -698.0% | at low |
| alltime | all time | -4397.2% | +23.2% | -5872.8% | +46.6% | <-9999.0% | at low |
Biohaven Pharmaceutical Holding Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$178.17 M(-46.6%) | -$848.89 M(+8.7%) |
| June 2024 | - | -$333.77 M(+82.2%) | -$781.27 M(+44.3%) |
| Mar 2024 | - | -$183.24 M(+19.2%) | -$541.51 M(+24.2%) |
| Dec 2023 | -$436.05 M(-23.2%) | -$153.71 M(+39.0%) | -$436.05 M(-12.0%) |
| Sept 2023 | - | -$110.55 M(+17.6%) | -$495.75 M(+9.5%) |
| June 2023 | - | -$94.01 M(+20.9%) | -$452.84 M(-18.5%) |
| Mar 2023 | - | -$77.78 M(-63.6%) | -$555.94 M(-2.1%) |
| Dec 2022 | -$567.93 M(+159.4%) | -$213.41 M(+215.5%) | -$567.93 M(+40.1%) |
| Sept 2022 | - | -$67.64 M(-65.7%) | -$405.40 M(+3.1%) |
| June 2022 | - | -$197.11 M(+119.6%) | -$393.26 M(+100.5%) |
| Mar 2022 | - | -$89.77 M(+76.4%) | -$196.15 M(+84.4%) |
| Dec 2021 | -$218.90 M(+91.2%) | - | - |
| Dec 2021 | - | -$50.88 M(-8.3%) | -$106.38 M(-53.0%) |
| Sept 2021 | - | -$55.49 M(-67.5%) | -$226.19 M(-65.0%) |
| Dec 2020 | -$114.51 M(-76.1%) | - | - |
| Dec 2020 | - | -$170.70 M(+4.6%) | -$645.39 M(+5.9%) |
| Sept 2020 | - | -$163.16 M(+1.6%) | -$609.69 M(+13.5%) |
| June 2020 | - | -$160.59 M(+6.4%) | -$536.98 M(-6.7%) |
| Mar 2020 | - | -$150.94 M(+11.8%) | -$575.61 M(+20.1%) |
| Dec 2019 | -$479.12 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | -$135.00 M(+49.3%) | -$479.12 M(+22.2%) |
| Sept 2019 | - | -$90.45 M(-54.6%) | -$392.19 M(+10.0%) |
| June 2019 | - | -$199.21 M(+265.8%) | -$356.67 M(+82.4%) |
| Mar 2019 | - | -$54.46 M(+13.3%) | -$195.58 M(-12.9%) |
| Dec 2018 | -$224.55 M(+108.7%) | - | - |
| Dec 2018 | - | -$48.07 M(-12.5%) | -$224.55 M(+9.7%) |
| Sept 2018 | - | -$54.94 M(+44.1%) | -$204.79 M(+8.1%) |
| June 2018 | - | -$38.12 M(-54.3%) | -$189.42 M(+7.3%) |
| Mar 2018 | - | -$83.44 M(+194.8%) | -$176.52 M(+64.1%) |
| Dec 2017 | -$107.58 M(+77.4%) | - | - |
| Dec 2017 | - | -$28.30 M(-28.5%) | -$107.58 M(+5.3%) |
| Sept 2017 | - | -$39.57 M(+56.9%) | -$102.13 M(+12.8%) |
| June 2017 | - | -$25.22 M(+74.0%) | -$90.52 M(+25.5%) |
| Mar 2017 | - | -$14.50 M(-36.5%) | -$72.15 M(+19.0%) |
| Dec 2016 | -$60.64 M(+525.4%) | - | - |
| Dec 2016 | - | -$22.84 M(-18.3%) | -$60.64 M(+60.4%) |
| Sept 2016 | - | -$27.96 M(+308.5%) | -$37.79 M(+284.5%) |
| June 2016 | - | -$6.85 M(+129.5%) | -$9.83 M(+229.5%) |
| Mar 2016 | - | -$2.98 M | -$2.98 M |
| Dec 2015 | -$9.70 M | - | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual operaing income?
- What is the all time high annual operating profit for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual operating profit year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly operating income?
- What is the all time high quarterly operating profit for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly operating profit year-on-year change?
- What is Biohaven Pharmaceutical Holding TTM operating income?
- What is the all time high TTM operating profit for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding TTM operating profit year-on-year change?
What is Biohaven Pharmaceutical Holding annual operaing income?
The current annual operating profit of BHVN is -$436.05 M
What is the all time high annual operating profit for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual operaing income is -$9.70 M
What is Biohaven Pharmaceutical Holding annual operating profit year-on-year change?
Over the past year, BHVN annual operaing income has changed by +$131.88 M (+23.22%)
What is Biohaven Pharmaceutical Holding quarterly operating income?
The current quarterly operating profit of BHVN is -$178.17 M
What is the all time high quarterly operating profit for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly operating income is -$2.98 M
What is Biohaven Pharmaceutical Holding quarterly operating profit year-on-year change?
Over the past year, BHVN quarterly operating income has changed by -$67.62 M (-61.17%)
What is Biohaven Pharmaceutical Holding TTM operating income?
The current TTM operating profit of BHVN is -$848.89 M
What is the all time high TTM operating profit for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high TTM operating income is -$2.98 M
What is Biohaven Pharmaceutical Holding TTM operating profit year-on-year change?
Over the past year, BHVN TTM operating income has changed by -$353.14 M (-71.23%)